Hagai Bergman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hagai Bergman has a total of 335 co-authors. Here are the top co-authors by number of shared publications:
Zvi Israel
Department of Neurosurgery, Hadassah University Hospital, Jerusalem, Israel
22 shared publications- Alexander Kaplan
Zuckerman Mind Brain Behavior Institute, Columbia University
7 shared publications - Aviv D. Mizrahi-Kliger
Department of Medical Neurobiology, Institute of Medical Research Israel – Canada, The Faculty of Medicine
7 shared publications - Jing Guang
Edmond and Lily Safra Center for Brain Sciences, The Hebrew University of Jerusalem, Jerusalem, Israel
6 shared publications Renana Eitan
Department of Medical Neurobiology, Institute of Medical Research Israel–Canada, Hadassah-Hebrew University Medical School, Jerusalem, 91120, Israel
5 shared publications- Zvi Israel
Hebrew University Hadassah Medical School: Hebrew University of Jerusalem School of Medicine
5 shared publications
Latest Publications
- Open Access
- 6 October 2026
- Published by Springer Nature in Research Square
Longitudinal tracking of ventral anteromedial subthalamic nucleus theta bursts in Obsessive Compulsive Disorder: bridging the gap towards a neurophysiological marker
Background: Deep Brain Stimulation (DBS) to treat treatment-resistant obsessive-compulsive disorder (OCD) is still considered off-label in most countries worldwide, despite numerous publications showing significant relief of symptoms and guidelines provided. To enhance therapeutic efficacy, there is an urgent need for further studies to refine stimulation target and promote patient-tailored adaptive DBS by identifying potential neurophysiological markers for OCD. However, limited research has investigated such markers so far. Methods: In this prospective interventional study, we implanted three refractory OCD patients (2 men and 1 woman) with ventral anteromedial subthalamic nucleus (vamSTN) DBS at the border with the OCD response tract (ORT). We recorded intra- and post-operatively spiking and local field potential (LFP) activity at the target for over two years to evaluate neural markers that correlate with OCD severity and clinical response. Outcomes: All patients responded to vamSTN DBS with a 54 ± 5·5% (18·6 ± 1·7 scores) mean reduction in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) at last follow-up. VamSTN LFP activity showed a prominent theta frequency peak. Theta burst duration, power, and entropy significantly correlated with OCD severity and stimulation-induced clinical response. Theta power was more robust and correlated more strongly with clinical scores in the left vamSTN. DBS response also resulted in a wake-sleep diurnal variation in theta power, which was larger in the left vamSTN. Interpretation: Due to the ease of vamSTN targeting, clinical efficacy, and the strong and stable neural biomarker, we suggest vamSTN theta burst power as a potential neural marker and possible target for adaptive DBS in OCD. Funding: The research was supported by the Israeli Science Foundation (ISF), Clalit healthcare services, the UTSW-Rabin medical center joint research grant and the Kahn Foundation. This study is registered in “ClinicalTrials.gov” (ID NCT05995951) under the name: “Deep Brain Stimulation Surgery for the Treatment of Refractory Obsessive-Compulsive Disorder”.
- 6 October 2026
- Published by Springer Nature in Research Square
Open AccessLongitudinal tracking of ventral anteromedial subthalamic nucleus theta bursts in Obsessive Compulsive Disorder: bridging the gap towards a neurophysiological marker
Background: Deep Brain Stimulation (DBS) to treat treatment-resistant obsessive-compulsive disorder (OCD) is still considered off-label in most countries worldwide, despite numerous publications showing significant relief of symptoms and guidelines provided. To enhance therapeutic efficacy, there is an urgent need for further studies to refine stimulation target and promote patient-tailored adaptive DBS by identifying potential neurophysiological markers for OCD. However, limited research has investigated such markers so far. Methods: In this prospective interventional study, we implanted three refractory OCD patients (2 men and 1 woman) with ventral anteromedial subthalamic nucleus (vamSTN) DBS at the border with the OCD response tract (ORT). We recorded intra- and post-operatively spiking and local field potential (LFP) activity at the target for over two years to evaluate neural markers that correlate with OCD severity and clinical response. Outcomes: All patients responded to vamSTN DBS with a 54 ± 5·5% (18·6 ± 1·7 scores) mean reduction in Yale-Brown Obsessive-Compulsive Scale (Y-BOCS) at last follow-up. VamSTN LFP activity showed a prominent theta frequency peak. Theta burst duration, power, and entropy significantly correlated with OCD severity and stimulation-induced clinical response. Theta power was more robust and correlated more strongly with clinical scores in the left vamSTN. DBS response also resulted in a wake-sleep diurnal variation in theta power, which was larger in the left vamSTN. Interpretation: Due to the ease of vamSTN targeting, clinical efficacy, and the strong and stable neural biomarker, we suggest vamSTN theta burst power as a potential neural marker and possible target for adaptive DBS in OCD. Funding: The research was supported by the Israeli Science Foundation (ISF), Clalit healthcare services, the UTSW-Rabin medical center joint research grant and the Kahn Foundation. This study is registered in “ClinicalTrials.gov” (ID NCT05995951) under the name: “Deep Brain Stimulation Surgery for the Treatment of Refractory Obsessive-Compulsive Disorder”.
- Open Access
A Protective Haplotype in trans Modifies Penetrance and Severity of TOR1A Dystonia
Introduction: Incomplete penetrance and variable expressivity characterize autosomal dominant neurological disorders, but their genetic determinants remain largely unknown. DYT-TOR1A dystonia provides a model for investigating incomplete penetrance. We aimed to identify modifiers of disease penetrance and severity beyond the known TOR1A c.646G>C modifier. Methods: In a prospective genotype-phenotype association study, we phenotyped Ashkenazi Jewish carriers of TOR1A c.907_909del using a prespecified five-level severity score. The primary analysis compared participants with no or minimal dystonia (scores 0-1) and severe dystonia (scores 3-4), after excluding c.646G>C carriers. Findings were assessed in an independent retrospective cohort. Sanger, exome, and short-read and long-read whole-genome sequencing were used for genotyping. Results: The prospective cohort included 61 carriers: 21 had severe dystonia and 28 had no or minimal dystonia, six of whom carried c.646G>C. Among the 43 participants in the primary analysis, haplotype A was identified in 33 (77%) and haplotype B in eight (19%). All haplotype B carriers had no or minimal dystonia (p=0.003). Haplotype B remained associated with a milder phenotype after including 12 participants with intermediate severity (p=0.006). The retrospective cohort included 147 carriers, 16 of whom carried c.646G>C. After their exclusion, dystonia manifested in 12 (38%) of 32 participants with haplotype B and 63 (64%) of 99 without it (p=0.009). Haplotype B was also associated with lower severity scores (p=0.011). Together, c.646G>C and local haplotype status predicted the phenotype of more than two-thirds of carriers. In silico analyses linked haplotype B to lower TOR1A and higher TOR1B expression in dystonia-relevant brain regions. Conclusion: A common local haplotype in trans to the disease-causing TOR1A variant was strongly associated with reduced penetrance and severity. These findings establish DYT-TOR1A dystonia as a model for investigating how local genetic variation contributes to incomplete penetrance in autosomal dominant neurological disorders.
Open AccessA Protective Haplotype in trans Modifies Penetrance and Severity of TOR1A Dystonia
Introduction: Incomplete penetrance and variable expressivity characterize autosomal dominant neurological disorders, but their genetic determinants remain largely unknown. DYT-TOR1A dystonia provides a model for investigating incomplete penetrance. We aimed to identify modifiers of disease penetrance and severity beyond the known TOR1A c.646G>C modifier. Methods: In a prospective genotype-phenotype association study, we phenotyped Ashkenazi Jewish carriers of TOR1A c.907_909del using a prespecified five-level severity score. The primary analysis compared participants with no or minimal dystonia (scores 0-1) and severe dystonia (scores 3-4), after excluding c.646G>C carriers. Findings were assessed in an independent retrospective cohort. Sanger, exome, and short-read and long-read whole-genome sequencing were used for genotyping. Results: The prospective cohort included 61 carriers: 21 had severe dystonia and 28 had no or minimal dystonia, six of whom carried c.646G>C. Among the 43 participants in the primary analysis, haplotype A was identified in 33 (77%) and haplotype B in eight (19%). All haplotype B carriers had no or minimal dystonia (p=0.003). Haplotype B remained associated with a milder phenotype after including 12 participants with intermediate severity (p=0.006). The retrospective cohort included 147 carriers, 16 of whom carried c.646G>C. After their exclusion, dystonia manifested in 12 (38%) of 32 participants with haplotype B and 63 (64%) of 99 without it (p=0.009). Haplotype B was also associated with lower severity scores (p=0.011). Together, c.646G>C and local haplotype status predicted the phenotype of more than two-thirds of carriers. In silico analyses linked haplotype B to lower TOR1A and higher TOR1B expression in dystonia-relevant brain regions. Conclusion: A common local haplotype in trans to the disease-causing TOR1A variant was strongly associated with reduced penetrance and severity. These findings establish DYT-TOR1A dystonia as a model for investigating how local genetic variation contributes to incomplete penetrance in autosomal dominant neurological disorders.
- Open Access
REM Sleep Disengagement of β Oscillations Permits Rapid Dream Movements in Parkinsonism
REM sleep behavior disorder is a hallmark of prodromal α-synucleinopathies, yet why patients with Parkinson's disease can generate rapid, coordinated movements during REM sleep despite daytime bradykinesia remains unknown. Here we combined recordings of eye movements, cortical electroencephalography, and basal ganglia-thalamic neuronal activity across vigilance states in non-human primates before and after MPTP-induced parkinsonism. Parkinsonism enhanced β oscillations and impaired movement-related neural dynamics during wakefulness and NREM sleep, whereas both pathological β activity and motor impairments were attenuated during REM sleep. β suppression preceded the onset of REM sleep, indicating that network reconfiguration begins before REM becomes behaviorally apparent. These findings demonstrate that Parkinsonian network dysfunction is dynamically gated by brain state rather than continuously imposed by dopamine depletion. REM sleep is a natural physiological condition in which β oscillations are disengaged, uncovering a latent capacity, normally masked by REM atonia, for rapid movement even in the dopamine-depleted motor network.
Open AccessREM Sleep Disengagement of β Oscillations Permits Rapid Dream Movements in Parkinsonism
REM sleep behavior disorder is a hallmark of prodromal α-synucleinopathies, yet why patients with Parkinson's disease can generate rapid, coordinated movements during REM sleep despite daytime bradykinesia remains unknown. Here we combined recordings of eye movements, cortical electroencephalography, and basal ganglia-thalamic neuronal activity across vigilance states in non-human primates before and after MPTP-induced parkinsonism. Parkinsonism enhanced β oscillations and impaired movement-related neural dynamics during wakefulness and NREM sleep, whereas both pathological β activity and motor impairments were attenuated during REM sleep. β suppression preceded the onset of REM sleep, indicating that network reconfiguration begins before REM becomes behaviorally apparent. These findings demonstrate that Parkinsonian network dysfunction is dynamically gated by brain state rather than continuously imposed by dopamine depletion. REM sleep is a natural physiological condition in which β oscillations are disengaged, uncovering a latent capacity, normally masked by REM atonia, for rapid movement even in the dopamine-depleted motor network.
- Open Access
- 23 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Entrained cortical delta–spindle activity, not periodic synchrony, prevents arousal by NREM thalamic bursts
Thalamic neurons discharge tonically during wakefulness and rapid-eye-movement (REM) sleep, but switch to burst firing during non-REM (NREM) sleep. It has been hypothesized that NREM thalamic bursts do not serve as a cortical “wake-up” signal due to their periodic and synchronized nature. Here, we analyze the simultaneously recorded polysomnographic signals, field potentials, and spiking activity of neurons in the ventral anterior and centromedian thalamic nuclei of two female non-human primates during naturally occurring vigilance states. These nuclei receive GABAergic output from the basal ganglia, with discharge rate decreasing during NREM sleep. Despite this reduction in inhibitory input, NREM bursting increases significantly as reported for glutamate-driven thalamic nuclei. The NREM bursts are neither periodic nor tightly synchronized. However, delta and sleep-spindle EEG activity and thalamic field potentials time-locked to burst onset during NREM sleep markedly differ from those observed during wakefulness and REM sleep. These results suggest that the basal ganglia modulate, rather than drive, their thalamic targets. Additionally, unique state-dependent thalamocortical dynamics, rather than the periodicity or tight synchrony of the thalamic bursts, are sufficient to account for why NREM thalamic bursts do not awaken the cortex.
- 23 January 2026
- Published by Springer Nature in Communications Biology
- Vol. 9 (1)
Open AccessEntrained cortical delta–spindle activity, not periodic synchrony, prevents arousal by NREM thalamic bursts
Thalamic neurons discharge tonically during wakefulness and rapid-eye-movement (REM) sleep, but switch to burst firing during non-REM (NREM) sleep. It has been hypothesized that NREM thalamic bursts do not serve as a cortical “wake-up” signal due to their periodic and synchronized nature. Here, we analyze the simultaneously recorded polysomnographic signals, field potentials, and spiking activity of neurons in the ventral anterior and centromedian thalamic nuclei of two female non-human primates during naturally occurring vigilance states. These nuclei receive GABAergic output from the basal ganglia, with discharge rate decreasing during NREM sleep. Despite this reduction in inhibitory input, NREM bursting increases significantly as reported for glutamate-driven thalamic nuclei. The NREM bursts are neither periodic nor tightly synchronized. However, delta and sleep-spindle EEG activity and thalamic field potentials time-locked to burst onset during NREM sleep markedly differ from those observed during wakefulness and REM sleep. These results suggest that the basal ganglia modulate, rather than drive, their thalamic targets. Additionally, unique state-dependent thalamocortical dynamics, rather than the periodicity or tight synchrony of the thalamic bursts, are sufficient to account for why NREM thalamic bursts do not awaken the cortex.
- Open Access
- 10 November 2025
- Published by Springer Nature in Research Square
Why bursts in thalamic nuclei receiving basal ganglia output fail to wake the cortex during sleep?
Thalamic neurons discharge tonically during wakefulness and rapid-eye-movement (REM) sleep, but burst during non-REM (NREM) sleep. It has been hypothesized that NREM thalamic bursts do not serve as a cortical "wake-up" signal due to their periodic and synchronized nature. To explore this hypothesis, we studied polysomnographic signals, field potentials, and spiking activity of multiple neurons in the ventral anterior and centromedian thalamic nuclei of two female non-human primates during naturally occurring vigilance states. These nuclei receive GABAergic output from the basal ganglia, with discharge rate decreasing during NREM sleep. Nevertheless, NREM bursting increased significantly as reported for glutamate-driven thalamic nuclei. NREM bursts were neither periodic nor tightly synchronized. However, EEG activity and thalamic field potentials time-locked to burst onset during NREM sleep markedly differed from those observed during wakefulness and REM sleep. These results suggest that NREM thalamic bursts do not awaken the cortex, due to unique state-dependent thalamocortical dynamics.
- 10 November 2025
- Published by Springer Nature in Research Square
Open AccessWhy bursts in thalamic nuclei receiving basal ganglia output fail to wake the cortex during sleep?
Thalamic neurons discharge tonically during wakefulness and rapid-eye-movement (REM) sleep, but burst during non-REM (NREM) sleep. It has been hypothesized that NREM thalamic bursts do not serve as a cortical "wake-up" signal due to their periodic and synchronized nature. To explore this hypothesis, we studied polysomnographic signals, field potentials, and spiking activity of multiple neurons in the ventral anterior and centromedian thalamic nuclei of two female non-human primates during naturally occurring vigilance states. These nuclei receive GABAergic output from the basal ganglia, with discharge rate decreasing during NREM sleep. Nevertheless, NREM bursting increased significantly as reported for glutamate-driven thalamic nuclei. NREM bursts were neither periodic nor tightly synchronized. However, EEG activity and thalamic field potentials time-locked to burst onset during NREM sleep markedly differed from those observed during wakefulness and REM sleep. These results suggest that NREM thalamic bursts do not awaken the cortex, due to unique state-dependent thalamocortical dynamics.
- Open Access
- 27 June 2025
- Published by Elsevier in Neuropharmacology
- Vol. 278, 110580
Embracing Diversity: Sedative effects vary across drug chemistry and frequency domains
- 27 June 2025
- Published by Elsevier in Neuropharmacology
- Vol. 278, 110580
Open AccessEmbracing Diversity: Sedative effects vary across drug chemistry and frequency domains
- Open Access
- 24 June 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. PP (15344320) , 1
Divide and Conquer: Automatic Detection of the Thalamus to Empower DBS Physiological Navigation to the Subthalamic Region
Objective: To identify thalamic electrophysiological activity along the trajectory to the subthalamic region using micro-electrode recordings in deep brain stimulation (DBS) surgery by integrating site- and sequence-based approaches, without compromising subthalamic nucleus (STN) detection accuracy. Methods: Electrophysiological data from 29,735 recording sites across 112 patients were used to develop algorithms for automatic detection of the thalamus, STN, and non-cellular brain areas. We combined site-specific features with sequence-based information using two approaches: classical machine learning using a support vector machine and a Gaussian-HMM (SVM-GHMM), and a recurrent neural network (LSTM). The performance of both algorithms was compared to the commercially available HaGuide STN-detection algorithm. We assess algorithm performance on thalamus and STN detection in pseudo-real-time using clinically relevant metrics. Results: Our algorithms achieved 73%-77% sensitivity and 97%-98% specificity for thalamus detection, and 94%-96% sensitivity and 98%-99% specificity for STN detection. The thalamus, with its electrophysiological heterogeneity, is particularly well-suited for sequence-based classification. The SVM-GHMM performed slightly better than the LSTM in clinical metrics for STN detection, though both were significantly better than HaGuide. Both models were also effective in identifying the thalamus and STN in the closely related case of trajectories targeting the nearby posterior subthalamic area. Conclusion: We demonstrated the ability to automatically identify thalamic activity along the trajectory to subthalamic region by leveraging site- and sequence-based algorithms, without compromising on STN detection accuracy. Significance: This study highlights the feasibility of real-time, automated thalamus and STN detection, offering valuable context to neurosurgeons during DBS surgery.
- 24 June 2025
- Published by Institute of Electrical and Electronics Engineers (IEEE) in IEEE Transactions on Neural Systems and Rehabilitation Engineering
- Vol. PP (15344320) , 1
Open AccessDivide and Conquer: Automatic Detection of the Thalamus to Empower DBS Physiological Navigation to the Subthalamic Region
Objective: To identify thalamic electrophysiological activity along the trajectory to the subthalamic region using micro-electrode recordings in deep brain stimulation (DBS) surgery by integrating site- and sequence-based approaches, without compromising subthalamic nucleus (STN) detection accuracy. Methods: Electrophysiological data from 29,735 recording sites across 112 patients were used to develop algorithms for automatic detection of the thalamus, STN, and non-cellular brain areas. We combined site-specific features with sequence-based information using two approaches: classical machine learning using a support vector machine and a Gaussian-HMM (SVM-GHMM), and a recurrent neural network (LSTM). The performance of both algorithms was compared to the commercially available HaGuide STN-detection algorithm. We assess algorithm performance on thalamus and STN detection in pseudo-real-time using clinically relevant metrics. Results: Our algorithms achieved 73%-77% sensitivity and 97%-98% specificity for thalamus detection, and 94%-96% sensitivity and 98%-99% specificity for STN detection. The thalamus, with its electrophysiological heterogeneity, is particularly well-suited for sequence-based classification. The SVM-GHMM performed slightly better than the LSTM in clinical metrics for STN detection, though both were significantly better than HaGuide. Both models were also effective in identifying the thalamus and STN in the closely related case of trajectories targeting the nearby posterior subthalamic area. Conclusion: We demonstrated the ability to automatically identify thalamic activity along the trajectory to subthalamic region by leveraging site- and sequence-based algorithms, without compromising on STN detection accuracy. Significance: This study highlights the feasibility of real-time, automated thalamus and STN detection, offering valuable context to neurosurgeons during DBS surgery.
- Open Access
- 28 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Basal ganglia deep brain stimulation restores cognitive flexibility and exploration-exploitation balance disrupted by NMDA-R antagonism
Learning thrives on cognitive flexibility and exploration. Subjects with schizophrenia have impaired cognitive flexibility and maladaptive exploration patterns. The basal ganglia-dorsolateral prefrontal cortex (BG-DLPFC) network plays a significant role in learning processes. However, how this network maintains cognitive flexibility and exploration patterns and what alters these patterns in schizophrenia remains elusive. Using a combination of extracellular recordings, pharmacological manipulations, macro-stimulation techniques, and mathematical modeling, we show that in the nonhuman primate (NHP), the external segment of the globus pallidus (GPe, the central nucleus of the BG network) modulates cognitive flexibility and exploration patterns (experiments were done in females only). We found that chronic, low-dose administration of N-methyl-D-aspartate receptor (NMDA-R) antagonist, phencyclidine (PCP), decreases directed exploration but increases random exploration, as seen in schizophrenia. In line with adaptive working-memory reinforcement-learning models of the BG-DLPFC network, low-frequency GPe macro-stimulation restores the balance of both exploration types. Our findings suggest that exploration-exploitation imbalance reflects abnormal BG-DLPFC activity and that GPe stimulation may restore it.
- 28 May 2025
- Published by Springer Nature in Nature Communications
- Vol. 16 (1) , 1-15
Open AccessBasal ganglia deep brain stimulation restores cognitive flexibility and exploration-exploitation balance disrupted by NMDA-R antagonism
Learning thrives on cognitive flexibility and exploration. Subjects with schizophrenia have impaired cognitive flexibility and maladaptive exploration patterns. The basal ganglia-dorsolateral prefrontal cortex (BG-DLPFC) network plays a significant role in learning processes. However, how this network maintains cognitive flexibility and exploration patterns and what alters these patterns in schizophrenia remains elusive. Using a combination of extracellular recordings, pharmacological manipulations, macro-stimulation techniques, and mathematical modeling, we show that in the nonhuman primate (NHP), the external segment of the globus pallidus (GPe, the central nucleus of the BG network) modulates cognitive flexibility and exploration patterns (experiments were done in females only). We found that chronic, low-dose administration of N-methyl-D-aspartate receptor (NMDA-R) antagonist, phencyclidine (PCP), decreases directed exploration but increases random exploration, as seen in schizophrenia. In line with adaptive working-memory reinforcement-learning models of the BG-DLPFC network, low-frequency GPe macro-stimulation restores the balance of both exploration types. Our findings suggest that exploration-exploitation imbalance reflects abnormal BG-DLPFC activity and that GPe stimulation may restore it.
- 13 March 2025
- Published by SAGE Publications in Laboratory Animals
- Vol. 59 (4) , 523-529
Innovative care protocol successfully rehabilitates non-human primates after MPTP-induced parkinsonism: Preliminary evidence from a restricted cohort of African Green Monkeys ( Chlorocebus sabaeus )
The MPTP-animal model of Parkinson’s disease has significantly advanced our understanding of Parkinson’s disease and the dopaminergic system, helping to establish disease mechanisms and develop therapeutic targets. The non-human primate (NHP) MPTP model is particularly valuable for replicating core Parkinson’s disease motor symptoms, anatomical changes and electrophysiological variations seen in humans. However, MPTP-injection protocols often cause substantial suffering, leading to euthanasia. While some post-MPTP primates recovered spontaneously, purposefully induced recovery was considered unattainable. Our team developed a novel intensive care protocol (NICP) promoting complete recovery from MPTP-induced severe parkinsonism in NHPs. NICP provides therapeutic, nutritional and social support, enabling behavioral recovery and subsequent retirement to a primate sanctuary. This innovation enhances animal welfare and opens new prospects for veterinary care, emphasizing the need to explore recovery mechanisms for other chronic conditions induced for research.
- 13 March 2025
- Published by SAGE Publications in Laboratory Animals
- Vol. 59 (4) , 523-529
Innovative care protocol successfully rehabilitates non-human primates after MPTP-induced parkinsonism: Preliminary evidence from a restricted cohort of African Green Monkeys ( Chlorocebus sabaeus )
The MPTP-animal model of Parkinson’s disease has significantly advanced our understanding of Parkinson’s disease and the dopaminergic system, helping to establish disease mechanisms and develop therapeutic targets. The non-human primate (NHP) MPTP model is particularly valuable for replicating core Parkinson’s disease motor symptoms, anatomical changes and electrophysiological variations seen in humans. However, MPTP-injection protocols often cause substantial suffering, leading to euthanasia. While some post-MPTP primates recovered spontaneously, purposefully induced recovery was considered unattainable. Our team developed a novel intensive care protocol (NICP) promoting complete recovery from MPTP-induced severe parkinsonism in NHPs. NICP provides therapeutic, nutritional and social support, enabling behavioral recovery and subsequent retirement to a primate sanctuary. This innovation enhances animal welfare and opens new prospects for veterinary care, emphasizing the need to explore recovery mechanisms for other chronic conditions induced for research.
- Open Access
- 30 January 2025
- Published by Wiley in Annals of Neurology
- Vol. 97 (5) , 826-844
Spiking Patterns in the Globus Pallidus Highlight Convergent Neural Dynamics across Diverse Genetic Dystonia Syndromes
Objective: Genetic dystonia is a complex movement disorder with diverse clinical manifestations resulting from pathogenic mutations in associated genes. A recent paradigm shift emphasizes the functional convergence among dystonia genes, hinting at a shared pathomechanism. However, the neural dynamics supporting this convergence remain largely unexplored.Methods: Herein, we analyzed microelectrode recordings acquired during pallidal deep brain stimulation surgery from 31 dystonia patients with pathogenic mutations in the AOPEP, GNAL, KMT2B, PANK2, PLA2G6, SGCE, THAP1, TOR1A, and VPS16 genes. We identified 1,694 single units whose activity was characterized by a broad set of neural features.Results: AOPEP, PANK2, and THAP1 displayed higher firing regularity, whereas GNAL, PLA2G6, KMT2B, and SGCE shared a large fraction of bursting neurons (> 26.6%), significantly exceeding the rate in other genes. TOR1A and VPS16 genes constituted an intermediate group, bridging these 2 groups, due to having the highest degree of spiking irregularity. Hierarchical clustering algorithms based on these dynamics confirmed the results obtained with first‐order comparisons.Interpretation: Despite lacking common molecular pathways, dystonia genes share largely overlapping structures of neural patterns, in particular the degree of pallidal spiking regularity and bursting activity. We propose that the degree of desynchronization facilitated by pallidal neural bursts may explain the variability in deep brain stimulation (DBS) of the globus pallidus internus (GPi) surgery outcomes across genetic dystonia syndromes. Lastly, investigating the effects of genetic mutations on low‐frequency pallidal activity could optimize personalized adaptive DBS treatments in patients with genetic dystonia. ANN NEUROL 2025;97:826–844
- 30 January 2025
- Published by Wiley in Annals of Neurology
- Vol. 97 (5) , 826-844
Open AccessSpiking Patterns in the Globus Pallidus Highlight Convergent Neural Dynamics across Diverse Genetic Dystonia Syndromes
Objective: Genetic dystonia is a complex movement disorder with diverse clinical manifestations resulting from pathogenic mutations in associated genes. A recent paradigm shift emphasizes the functional convergence among dystonia genes, hinting at a shared pathomechanism. However, the neural dynamics supporting this convergence remain largely unexplored.Methods: Herein, we analyzed microelectrode recordings acquired during pallidal deep brain stimulation surgery from 31 dystonia patients with pathogenic mutations in the AOPEP, GNAL, KMT2B, PANK2, PLA2G6, SGCE, THAP1, TOR1A, and VPS16 genes. We identified 1,694 single units whose activity was characterized by a broad set of neural features.Results: AOPEP, PANK2, and THAP1 displayed higher firing regularity, whereas GNAL, PLA2G6, KMT2B, and SGCE shared a large fraction of bursting neurons (> 26.6%), significantly exceeding the rate in other genes. TOR1A and VPS16 genes constituted an intermediate group, bridging these 2 groups, due to having the highest degree of spiking irregularity. Hierarchical clustering algorithms based on these dynamics confirmed the results obtained with first‐order comparisons.Interpretation: Despite lacking common molecular pathways, dystonia genes share largely overlapping structures of neural patterns, in particular the degree of pallidal spiking regularity and bursting activity. We propose that the degree of desynchronization facilitated by pallidal neural bursts may explain the variability in deep brain stimulation (DBS) of the globus pallidus internus (GPi) surgery outcomes across genetic dystonia syndromes. Lastly, investigating the effects of genetic mutations on low‐frequency pallidal activity could optimize personalized adaptive DBS treatments in patients with genetic dystonia. ANN NEUROL 2025;97:826–844